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Abstract
The metabolic syndrome has been shown to increase risk for cardiovascular disease and diabetes. 
The Atherosclerosis Risk in Communities study enrolled 15,792 middle-aged Americans in 4 
communities in the United States and has followed them for the development of cardiovascular 
disease and diabetes. Several analyses from this large, biracial, population study have shown that 
the metabolic syndrome, as well as individual metabolic syndrome components, is predictive of 
the prevalence and incidence of coronary heart disease, ischemic stroke, carotid artery disease, and 
diabetes.
Keywords
metabolic syndrome; coronary heart disease; cardiovascular disease; diabetes; risk factors
 Introduction
The metabolic syndrome has been shown to increase risk for cardiovascular disease (CVD) 
and diabetes and was established as a secondary target of therapy in the Adult Treatment 
Panel III (ATP III) guidelines of the U.S. National Cholesterol Education Program.1 
According to the ATP III definition, the metabolic syndrome is diagnosed by the presence of 
3 or more of the following characteristics: waist circumference >40 inches (102 cm) in men, 
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>35 inches (88 cm) in women; triglycerides ≥150 mg/dL; high-density lipoprotein 
cholesterol (HDL-C) <40 mg/dL in men, <50 mg/dL in women; blood pressure ≥130/≥85 
mm Hg; and fasting glucose 110–125 mg/dL.2 Data from the U.S. National Health and 
Nutrition Examination Survey indicate that age-adjusted prevalence of the metabolic 
syndrome, as defined by the ATP III guidelines, is 27% in adults and has been increasing.3
The role of the metabolic syndrome and its individual components in predicting risk for 
CVD and diabetes has been examined in the Atherosclerosis Risk in Communities (ARIC) 
study, a large, prospective, biracial cohort study of cardiovascular risk factors in 15,792 
middle-aged (aged 45–64 years) Americans.4 Analyses have evaluated the influence of the 
metabolic syndrome on both prevalence and incidence of CVD as well as on the prediction 
of diabetes.
 Metabolic Syndrome and Prevalence of CVD
In a cross-sectional analysis of 14,502 ARIC participants, using data from 1987–1989, 
prevalence of the metabolic syndrome as defined by ATP III was 30%, with considerable 
variation across subgroups defined by sex and race.5 The highest metabolic syndrome 
prevalence was in black women (38%), and the lowest was in black men (26%); 31% of 
white men and 28% of white women had the metabolic syndrome.
After adjustment for age, ARIC center, low-density lipoprotein cholesterol (LDL-C) level, 
and smoking status, ARIC participants who had the metabolic syndrome were 2 times more 
likely to have prevalent coronary heart disease (CHD; defined as prior myocardial infarction 
or cardiovascular revascularization) than participants without the metabolic syndrome.5 For 
each subgroup defined by sex and race, prevalence of CHD (without this adjustment) was 
significantly higher in individuals with than in individuals without the metabolic syndrome, 
with the highest CHD prevalence being in white men with the metabolic syndrome (13%, 
compared with 7% in white men without the metabolic syndrome). Among participants with 
the metabolic syndrome in other subgroups, CHD prevalence was 11% in black men 
(compared with 4% in black men without the metabolic syndrome), 4% in black women 
(compared with 2% in black women without the metabolic syndrome), and 3% in white 
women (compared with 1% in white women without the metabolic syndrome).
The extent of carotid artery atherosclerosis, assessed by intima–media thickness (IMT) 
determined by B-mode ultrasound, was also significantly greater in ARIC participants with 
the metabolic syndrome.5 Mean IMT for 6 segments (carotid bifurcation, common carotid, 
and internal carotid in left and right carotid arteries) was 747 μm in individuals with and 704 
μm in individuals without the metabolic syndrome. After adjustment for age, ARIC center, 
LDL-C level, smoking status, lipoprotein(a) level, and white blood cell count, IMT in 
individuals with the metabolic syndrome was 38 μm greater in both white men and white 
women, 29 μm greater in black women, and 27 μm in black men compared with the 
corresponding subgroups without the metabolic syndrome.
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 Metabolic Syndrome and Incidence of CVD
The incidence of CHD and ischemic stroke over a mean 11-year follow-up was also assessed 
in ARIC participants with and without the metabolic syndrome. In this analysis of data from 
12,089 individuals without diabetes, CHD, or stroke at baseline, prevalence of the metabolic 
syndrome as defined by ATP III was 23%.6 Incident CHD was defined as fatal or nonfatal 
CHD, silent myocardial infarction identified by electrocardiography, or coronary 
revascularization. The crude incidence rate of CHD per 10,000 person-years was 
significantly higher in both men and women with the metabolic syndrome (138.4 and 57.5, 
respectively) compared with men and women without (92.3 and 22.7, respectively). After 
adjustment for age, race/ARIC center, LDL-C level, and smoking status, the hazard ratio 
[HR] for incident CHD in ARIC participants with versus without the metabolic syndrome 
was 1.46 (95% confidence interval [CI] 1.23–1.74) in men and 2.05 (95% CI 1.59–2.64) in 
women (p <0.03 for sex interaction). The metabolic syndrome components most strongly 
associated with incident CHD were elevated blood pressure and low high-density lipoprotein 
cholesterol (HDL-C) level. Risk for CHD increased with the number of metabolic syndrome 
components present; among individuals with 4 or more components present, the HR for 
incident CHD was 2.23 (95% CI 1.64–3.04) in men and 5.25 (95% CI 3.10–8.89) in women, 
compared with the respective subgroups with no components of the metabolic syndrome 
(Figure 1). Applying the lower threshold for impaired fasting glucose (100 mg/dL)7 to the 
metabolic syndrome did not change the magnitude of observed associations between the 
metabolic syndrome and either CHD or stroke estimated from the original ATP III 
definition. In multivariable-adjusted models that included all individual components of the 
metabolic syndrome, risk for CHD associated with the presence of the metabolic syndrome 
was not in excess of the risk explained by its individual components. Also, a comparison of 
receiver operating characteristic curves (ROCs) estimated from logistic regression indicated 
that identification of the metabolic syndrome did not improve CHD risk prediction beyond 
the Framingham risk score.
The crude incidence rate of ischemic stroke per 10,000 person-years was also significantly 
higher in ARIC participants with the metabolic syndrome (24.6 in men and 19.0 in women, 
versus 18.1 and 8.5 in men and women, respectively, without the metabolic syndrome). After 
adjustment for age, race/ARIC center, LDL-C level, and smoking status, the HR for incident 
ischemic stroke in ARIC participants with versus without the metabolic syndrome was 1.42 
(95% CI 0.96–2.11) in men and 1.96 (95% CI 1.28–3.00) in women.
 Metabolic Syndrome and Prediction of Diabetes
In addition to increasing risk for CVD, the metabolic syndrome increases risk for diabetes. 
In an analysis of 7,915 ARIC participants without diabetes at baseline, panels of risk factors 
and presence of the metabolic syndrome were assessed for their predictivity for incident 
diabetes over 9 years of follow-up.8 For the risk factor panels, models that included fasting 
glucose, triglycerides, and HDL-C in addition to clinical variables (sex, ethnicity, parental 
history of diabetes, systolic blood pressure, waist, height; area under the ROC curve 
[AUC]=0.80, 95% confidence interval [CI] 0.78–0.82) were significantly better for 
predicting incident diabetes than clinical variables alone (AUC=0.71, 95% CI 0.69–0.73). 
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However, in a model that assigned 1 point for each criterion of the metabolic syndrome and 
additional points for obesity and elevated fasting glucose, a score of 3 or more labeled 46% 
of participants as high risk and identified 81% of future cases of diabetes (AUC=0.78, 95% 
CI 0.76–0.80). The investigators concluded that rules based on the metabolic syndrome, 
which may be easier to apply in clinical settings, though slightly less predictive, are valid 
alternatives to more complex and complete risk function equations.
In a similar investigation evaluating strategies to detect prevalent diabetes not diagnosed by 
fasting glucose, ARIC investigators evaluated the use of the metabolic syndrome to detect 
individuals classified as having diabetes by a 2-hour glucose value ≥200 mg/dL during a 75-
g oral glucose tolerance test. The presence of 3 or more ATP III–defined metabolic 
syndrome abnormalities, while labeling 28% of the sample as positive, identified 40% of 
individuals with undetected diabetes with a specificity of 72%. By comparison, a clinical 
prediction rule composed of clinical findings, fasting glucose, HDL-C, and triglycerides, 
while labeling 30% of the sample as positive, identified 56% of individuals with undetected 
diabetes with a specificity of 71%.9
 Summary
The metabolic syndrome is associated with prevalence and incidence of CHD, stroke, and 
increased carotid IMT in middle-aged Americans. Although the prediction of incident CHD 
was not better than with Framingham risk score, most physicians in clinical practice do not 
use Framingham risk score.10 Furthermore, the metabolic syndrome was also highly 
predictive for development of diabetes. Thus, the simple clinical criteria of the metabolic 
syndrome may be helpful in identifying middle-aged individuals with clustered risk factors 
who may benefit from more intensive lifestyle modification and pharmacotherapy 
accompanied by weight loss to reduce the risk for developing CVD and diabetes.
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Figure 1. Association of coronary heart disease (CHD) risk with metabolic syndrome 
components in ARIC
After adjustment for age, race/ARIC center, LDL-C, and smoking status, risk for CHD over 
11 years increased with the number of metabolic syndrome components present at baseline.6
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Figure 2. Predictivity of models for development of incident diabetes in ARIC
Percent of ARIC participants with incident diabetes by decile of estimated risk (left panel) 
and percent of individuals in each decile of estimated risk who developed diabetes during 9 
years of follow-up (right panel). Models: clinical information (age, race, parental history of 
diabetes, systolic blood pressure, waist, height), gray bars; fasting glucose, white bars; 
clinical information plus fasting glucose, black bars; clinical information, fasting glucose, 
HDL-C, and triglycerides, diagonally striped bars.8
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